drugset / Trial / NCT00703144

Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy

NCT00703144

Phase 4 Completed 10 enrolled University Hospital, Toulouse
NaSingle-groupOpen-labelTreatment

Summary

The pharmacokinetics of piperacillin/tazobactam will be evaluated in twenty septic patients with renal failure undergoing continuous veno-venous hemodiafiltration.

Timeline

Start
2008-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Piperacillin Small molecule 4 g Intravenous
Subject Tazobactam Small molecule 500 mg Intravenous

Indications

No indication recorded.